PeopleJames Noble
James Noble
James NobleNon-Executive ChairmanJames joined Pneumagen as Non-Executive Chairman of the Board in 2023. James has over 30 years of industry experience across both public and private biotech and healthcare companies. He is also Chairman at Orexo AB, Sutura Therapeutics and Ingenox, previously Celleron Therapeutics and Non-Executive Director of Lava Therapeutics N.V. James has held non-executive roles at several prominent biotech companies including MediGene AG, PowderJect, Oxford GlycoSciences, CuraGen, Advanced Medical Solutions and GW Pharmaceuticals.In 2008, James founded Adaptimmune, a Nasdaq listed T-cell therapy company, where he worked as Chief Executive Officer until 2019. Prior to this, James worked as Chief Executive Officer of Immunocore, which he also co-founded. Mr. Noble qualified as a chartered accountant with Price Waterhouse and holds an M.A. degree from the University of Oxford.
active0
Roles
team_memberboard_chairexecutive
Timeline
Current Company
